Medicare Rx: FINANCIAL ANALYSTS: DRUG-ONLY PLANS A NO-GO
The Medicare prescription-drug legislation being debated in Washington proposes private drug-only insurance plans - presumably operated by pharmacy benefit management companies - that would take on some insurance risk to participate in the program. Two financial analysts at a June 18 forum sponsored by the Center for Studying Health System Change had a word for that scenario: impossible.
"I do not see any PBMs absorbing risk," said Alliance Capital Management Senior Vice President Norm Fidel. In normal business practice, PBMs manage drug benefits as an insurance company carve-out and take only administrative risk, said Fidel.
In the past...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: